Corporate Counsel Weekly™ helps corporate lawyers get the big picture on the legal challenges facing corporations today. Practitioners can discover trends on the horizon and stay alert to the full...
June 10 — Kirkland & Ellis LLP should no longer represent Teva Pharmaceutical Industries Ltd. in its hostile bid for Mylan NV, a federal magistrate ruled June 9. In a report and recommendation, U.S. Magistrate Judge Lisa Pupo Lenihan said Kirkland's past work for Mylan—despite a retainer agreement that seemed to anticipate the potential for future representation of a competitor—should disqualify the firm. “We strongly disagree with the recommendation made by the magistrate judge, and we reject any suggestion that Kirkland & Ellis's representation of Teva in its proposed acquisition of Mylan NV presents a conflict of interest,” the Chicago-based firm said in an e-mailed statement. The ruling stems from a protracted three-way takeover battle. Teva in April proposed buying Mylan for $40.1 billion in cash and stock. Mylan rejected that offer, saying that it preferred to go ahead with its attempt to buy drugmaker Perrigo Co. for about $32.7 billion (Mylan Inc. v Kirkland & Ellis LLP, W.D. Pa., 2:15- cv-00581, 6/9/15).
©2015 Bloomberg L.P. All rights reserved. Used with permission
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)